Targeted Therapies Do Not Increase Cardiovascular Risk in Psoriasis
Researchers sought to investigate the effect of targeted therapies on cardiovascular risk in psoriasis and psoriatic arthritis.
Diagnosis & Disease Information
Clinical Challenge: Progression of Palpable Purpura to Bullous Plaques
A 20-year-old woman presents to the dermatology clinic with a 5-day history of a mildly pruritic rash on both of her legs and feet. Can you diagnose this condition?
2022 EULAR Recommendations for Prophylaxis of Infections in Patients With Rheumatic Diseases
The EULAR issued recommendations for the screening and prophylaxis of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases.
Prevalence of Axial Pain and Arthritis Assessed in Inflammatory Bowel Disease
Using NHANES data, researchers estimated the prevalence of chronic axial pain, inflammatory back pain, axial spondyloarthritis, and peripheral arthritis in inflammatory bowel disease.
Anticentromere Antibodies Can Serve as Diagnostic Marker for Sjögren Syndrome
A team of researchers from Japan studied the presence of Sjögren syndrome among patients with anticentromere antibodies.
Posimir Now Available for Postsurgical Analgesia Following Shoulder Surgery
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
Significant Improvements Seen With Bimekizumab in Ankylosing Spondylitis Trial
The ongoing phase 3 BE MOBILE 2 study compared the efficacy and safety of bimekizumab to placebo in 332 adults with active ankylosing spondylitis.
Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis
The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.
Rinvoq Approved for Active Ankylosing Spondylitis
The approval was based on data from the phase 2/3 SELECT-AXIS 1 and the phase 3 SELECT-AXIS 2 trials.
EULAR Recommendations for CV Risk Management in Rheumatic and Musculoskeletal Diseases
A EULAR task force recently developed recommendations for the management of cardiovascular risk in patients with rheumatic and musculoskeletal diseases, including gout, lupus, and systemic sclerosis.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...